{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:06:04Z","timestamp":1789740364855,"version":"4.0.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-026-01607-6","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:36:12Z","timestamp":1789738572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteoporosis and Skeletal Fragility in non-Metastatic Pheochromocytomas and Paragangliomas: The Adrenergic-Skeletal Axis"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8633-7700","authenticated-orcid":false,"given":"Alberto","family":"Vassallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-0612","authenticated-orcid":false,"given":"Filippo","family":"Raggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"1607_CR1","doi-asserted-by":"crossref","unstructured":"Saavedra TJS, Nati-Castillo HA, Valderrama Cometa LA et al (2024) Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment. Front Endocrinol (Lausanne) Volume 15\u20132024","DOI":"10.3389\/fendo.2024.1433582"},{"key":"1607_CR2","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1007\/s40618-025-02639-9","volume":"48","author":"G Vitturi","year":"2025","unstructured":"Vitturi G, Crisafulli S, Alessi Y et al (2025) Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies. J Endocrinol Invest 48:2813\u20132825. https:\/\/doi.org\/10.1007\/s40618-025-02639-9","journal-title":"J Endocrinol Invest"},{"key":"1607_CR3","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.beem.2020.101416","volume":"34","author":"A Buffet","year":"2020","unstructured":"Buffet A, Burnichon N, Favier J, Gimenez-Roqueplo A-P (2020) An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab 34:101416. https:\/\/doi.org\/10.1016\/j.beem.2020.101416","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1607_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S2213-8587(23)00256-5","volume":"11","author":"MA Nazari","year":"2023","unstructured":"Nazari MA, Hasan R, Haigney M et al (2023) Catecholamine-induced hypertensive crises: current insights and management. Lancet Diabetes Endocrinol 11:942\u2013954. https:\/\/doi.org\/10.1016\/S2213-8587(23)00256-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1607_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12020-019-02035-3","volume":"65","author":"S Y-Hassan","year":"2019","unstructured":"Y-Hassan S, Falhammar H (2019) Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome. Endocrine 65:483\u2013493. https:\/\/doi.org\/10.1007\/s12020-019-02035-3","journal-title":"Endocrine"},{"key":"1607_CR6","doi-asserted-by":"crossref","unstructured":"Constantinescu G, Preda C, Constantinescu V et al (2022) Silent pheochromocytoma and paraganglioma: systematic review and proposed definitions for standardized terminology. Front Endocrinol (Lausanne) Volume 13\u20132022","DOI":"10.3389\/fendo.2022.1021420"},{"key":"1607_CR7","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.dsx.2020.10.030","volume":"14","author":"S Khatiwada","year":"2020","unstructured":"Khatiwada S, Agarwal S, Kandasamy D et al (2020) Diabetes mellitus in pheochromocytoma and paraganglioma: prevalence, dynamics of insulin secretion \/ sensitivity and predictors of remission. Diabetes Metabolic Syndrome: Clin Res Reviews 14:2169\u20132175. https:\/\/doi.org\/10.1016\/j.dsx.2020.10.030","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"key":"1607_CR8","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1210\/clinem\/dgag069","volume":"111","author":"H Alkaissi","year":"2026","unstructured":"Alkaissi H, Pacak K, Gordon CM (2026) Effects of catecholamines on bone and mineral metabolism in patients with pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 111:1813\u20131819","journal-title":"J Clin Endocrinol Metab"},{"key":"1607_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12018-019-9257-4","volume":"17","author":"B-J Kim","year":"2019","unstructured":"Kim B-J, Lee SH, Koh J-M (2019) Effects of Sympathetic Activity on Human Skeletal Homeostasis: clinical evidence from pheochromocytoma. Clin Rev Bone Min Metab 17:40\u201347. https:\/\/doi.org\/10.1007\/s12018-019-9257-4","journal-title":"Clin Rev Bone Min Metab"},{"key":"1607_CR10","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1507\/endocrj.EJ25-0117","volume":"72","author":"M Yokomoto-Umakoshi","year":"2025","unstructured":"Yokomoto-Umakoshi M, Umakoshi H, Ogawa Y (2025) Imbalances in adrenal hormones and their effects on bone metabolism. Endocr J 72:1287\u20131297. https:\/\/doi.org\/10.1507\/endocrj.EJ25-0117","journal-title":"Endocr J"},{"key":"1607_CR11","doi-asserted-by":"crossref","unstructured":"Liu M, Liu Y, Yu J et al (2025) Molecular mechanisms and therapeutic implications of the sympathetic nervous system in bone-related disorders: a brain-bone axis perspective. Bone Res 13","DOI":"10.1038\/s41413-025-00494-1"},{"key":"1607_CR12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1152\/physrev.00014.2017","volume":"98","author":"F Elefteriou","year":"2018","unstructured":"Elefteriou F (2018) Impact of the autonomic nervous system on the skeleton. Physiol Rev 98:1083\u20131112. https:\/\/doi.org\/10.1152\/physrev.00014.2017","journal-title":"Physiol Rev"},{"key":"1607_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bonr.2018.11.002","volume":"9","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Ma Y, Elefteriou F (2018) Cortical bone is an extraneuronal site of norepinephrine uptake in adult mice. Bone Rep 9:188\u2013198. https:\/\/doi.org\/10.1016\/j.bonr.2018.11.002","journal-title":"Bone Rep"},{"key":"1607_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.bbrc.2016.11.011","volume":"488","author":"Q Yao","year":"2017","unstructured":"Yao Q, Liang H, Huang B et al (2017) Beta-adrenergic signaling affect osteoclastogenesis via osteocytic MLO-Y4 cells\u2019 RANKL production. Biochem Biophys Res Commun 488:634\u2013640. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.011","journal-title":"Biochem Biophys Res Commun"},{"key":"1607_CR15","doi-asserted-by":"publisher","first-page":"8967","DOI":"10.12998\/wjcc.v9.i30.8967","volume":"9","author":"X-P Zhong","year":"2021","unstructured":"Zhong X-P, Xia W-F (2021) Regulation of bone metabolism mediated by \u03b2-adrenergic receptor and its clinical application. World J Clin Cases 9:8967\u20138973. https:\/\/doi.org\/10.12998\/wjcc.v9.i30.8967","journal-title":"World J Clin Cases"},{"key":"1607_CR16","doi-asserted-by":"publisher","first-page":"E507","DOI":"10.1152\/ajpendo.00191.2012","volume":"304","author":"H Kondo","year":"2012","unstructured":"Kondo H, Takeuchi S, Togari A (2012) \u03b2-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species. Am J Physiology-Endocrinology Metabolism 304:E507\u2013E515. https:\/\/doi.org\/10.1152\/ajpendo.00191.2012","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"1607_CR17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00774-020-01132-y","volume":"38","author":"C Mo","year":"2020","unstructured":"Mo C, Ke J, Zhao D, Zhang B (2020) Role of the renin\u2013angiotensin\u2013aldosterone system in bone metabolism. J Bone Min Metab 38:772\u2013779. https:\/\/doi.org\/10.1007\/s00774-020-01132-y","journal-title":"J Bone Min Metab"},{"key":"1607_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.intimp.2019.04.023","volume":"72","author":"J Zhao","year":"2019","unstructured":"Zhao J, Yang H, Chen B, Zhang R (2019) The skeletal renin-angiotensin system: a potential therapeutic target for the treatment of osteoarticular diseases. Int Immunopharmacol 72:258\u2013263. https:\/\/doi.org\/10.1016\/j.intimp.2019.04.023","journal-title":"Int Immunopharmacol"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"100047","DOI":"10.1016\/j.medntd.2020.100047","volume":"8","author":"L Do Carmo","year":"2020","unstructured":"Do Carmo L, Harrison DG (2020) Hypertension and osteoporosis: common pathophysiological mechanisms. Med Nov Technol Devices 8:100047. https:\/\/doi.org\/10.1016\/j.medntd.2020.100047","journal-title":"Med Nov Technol Devices"},{"key":"1607_CR20","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1210\/en.2010-0881","volume":"152","author":"Y Ma","year":"2011","unstructured":"Ma Y, Nyman JS, Tao H et al (2011) \u03b22-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone. Endocrinology 152:1412\u20131422. https:\/\/doi.org\/10.1210\/en.2010-0881","journal-title":"Endocrinology"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"2207602","DOI":"10.1002\/advs.202207602","volume":"10","author":"Q Guo","year":"2023","unstructured":"Guo Q, Chen N, Qian C et al (2023) Sympathetic innervation regulates osteocyte-mediated cortical bone resorption during lactation. Adv Sci 10:2207602. https:\/\/doi.org\/10.1002\/advs.202207602","journal-title":"Adv Sci"},{"key":"1607_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1210\/en.2008-0843","volume":"150","author":"ML Bouxsein","year":"2009","unstructured":"Bouxsein ML, Devlin MJ, Glatt V et al (2009) Mice lacking \u03b2-Adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy. Endocrinology 150:144\u2013152. https:\/\/doi.org\/10.1210\/en.2008-0843","journal-title":"Endocrinology"},{"key":"1607_CR23","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/jbmr.1594","volume":"27","author":"DD Pierroz","year":"2012","unstructured":"Pierroz DD, Bonnet N, Bianchi EN et al (2012) Deletion of \u03b2-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation. J Bone Miner Res 27:1252\u20131262. https:\/\/doi.org\/10.1002\/jbmr.1594","journal-title":"J Bone Miner Res"},{"key":"1607_CR24","doi-asserted-by":"publisher","first-page":"e10712","DOI":"10.1002\/jbm4.10712","volume":"7","author":"E Worton","year":"2023","unstructured":"Worton E, Srinivasan L, Threet S D, et al (2023) Beta 2 adrenergic receptor selective antagonist enhances mechanically stimulated bone anabolism in aged mice. JBMR Plus 7:e10712. https:\/\/doi.org\/10.1002\/jbm4.10712","journal-title":"JBMR Plus"},{"key":"1607_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00223-010-9421-9","volume":"88","author":"H Kondo","year":"2011","unstructured":"Kondo H, Togari A (2011) Continuous treatment with a low-dose \u03b2-Agonist reduces bone mass by increasing bone resorption without suppressing bone formation. Calcif Tissue Int 88:23\u201332. https:\/\/doi.org\/10.1007\/s00223-010-9421-9","journal-title":"Calcif Tissue Int"},{"key":"1607_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0167-4889(03)00042-9","volume":"1640","author":"M Arai","year":"2003","unstructured":"Arai M, Nagasawa T, Koshihara Y et al (2003) Effects of \u03b2-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochimica et Biophysica Acta (BBA) -. Mol Cell Res 1640:137\u2013142. https:\/\/doi.org\/10.1016\/S0167-4889(03)00042-9","journal-title":"Mol Cell Res"},{"key":"1607_CR27","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00198-007-0354-8","volume":"18","author":"C Meisinger","year":"2007","unstructured":"Meisinger C, Heier M, Lang O, D\u00f6ring A (2007) [beta]-blocker use and risk of fractures in men and women from the general population: the MONICA\/KORA Augsburg cohort study. Osteoporos Int 18:1189. https:\/\/doi.org\/10.1007\/s00198-007-0354-8","journal-title":"Osteoporos Int"},{"key":"1607_CR28","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of \u03b2-blockers and risk of fractures. JAMA: J Am Med Association 292:1326\u20131332. https:\/\/doi.org\/10.1001\/jama.292.11.1326","journal-title":"JAMA: J Am Med Association"},{"key":"1607_CR29","doi-asserted-by":"publisher","unstructured":"Gage BF, Birman-Deych E, Radford MJ et al (2006) risk of osteoporotic fracture in elderly patients taking warfarin: results from the national registry of atrial fibrillation 2. Archives of internal medicine (1960) 166:241\u2013246. https:\/\/doi.org\/10.1001\/archinte.166.2.241","DOI":"10.1001\/archinte.166.2.241"},{"key":"1607_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00223-006-0213-1","volume":"80","author":"F de Vries","year":"2007","unstructured":"de Vries F, Souverein PC, Cooper C et al (2007) Use of \u03b2-Blockers and the Risk of Hip\/Femur Fracture in the United Kingdom and The Netherlands. Calcif Tissue Int 80:69\u201375. https:\/\/doi.org\/10.1007\/s00223-006-0213-1","journal-title":"Calcif Tissue Int"},{"key":"1607_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00198-013-2498-z","volume":"25","author":"KA Toulis","year":"2014","unstructured":"Toulis KA, Hemming K, Stergianos S et al (2014) \u03b2-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects. Osteoporos Int 25:121\u2013129. https:\/\/doi.org\/10.1007\/s00198-013-2498-z","journal-title":"Osteoporos Int"},{"key":"1607_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00198-025-07471-8","volume":"36","author":"L Liu","year":"2025","unstructured":"Liu L, Wang Y, Tan B, Huang P (2025) Association of \u03b2-adrenergic receptor blockers use with the risk of fracture in adults: a systematic review and meta-analysis. Osteoporos Int 36:995\u20131005. https:\/\/doi.org\/10.1007\/s00198-025-07471-8","journal-title":"Osteoporos Int"},{"key":"1607_CR33","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1517\/13543784.17.9.1281","volume":"17","author":"S Graham","year":"2008","unstructured":"Graham S, Hammond-Jones D, Gamie Z et al (2008) The effect of \u03b2-blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing. Expert Opin Investig Drugs 17:1281\u20131299. https:\/\/doi.org\/10.1517\/13543784.17.9.1281","journal-title":"Expert Opin Investig Drugs"},{"key":"1607_CR34","doi-asserted-by":"publisher","first-page":"17174","DOI":"10.1074\/jbc.M113.546135","volume":"289","author":"T Hirai","year":"2014","unstructured":"Hirai T, Tanaka K, Togari A (2014) Adrenergic receptor signaling in osteoblasts regulates clock genes and bone morphogenetic protein 4 expression through Up-regulation of the transcriptional factor nuclear factor IL-3 (Nfil3)\/E4 promoter-binding protein 4 (E4BP4) *. J Biol Chem 289:17174\u201317183. https:\/\/doi.org\/10.1074\/jbc.M113.546135","journal-title":"J Biol Chem"},{"key":"1607_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jcp.21761","volume":"220","author":"HH Huang","year":"2009","unstructured":"Huang HH, Brennan TC, Muir MM, Mason RS (2009) Functional \u03b11- and \u03b22-adrenergic receptors in human osteoblasts. J Cell Physiol 220:267\u2013275. https:\/\/doi.org\/10.1002\/jcp.21761","journal-title":"J Cell Physiol"},{"key":"1607_CR36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00198-015-3312-x","volume":"27","author":"EJ Limonard","year":"2016","unstructured":"Limonard EJ, Schoenmaker T, de Vries TJ et al (2016) Clonidine increases bone resorption in humans. Osteoporos Int 27:1063\u20131071. https:\/\/doi.org\/10.1007\/s00198-015-3312-x","journal-title":"Osteoporos Int"},{"key":"1607_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.11005\/jbm.2015.22.1.29","volume":"22","author":"G-H Seo","year":"2015","unstructured":"Seo G-H, Lee Y-K, Ha Y-C (2015) Risk of hip fractures in men with alpha-blockers: a nationwide study base on claim registry. J Bone Metab 22:29\u201332. https:\/\/doi.org\/10.11005\/jbm.2015.22.1.29","journal-title":"J Bone Metab"},{"key":"1607_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12882-024-03892-5","volume":"25","author":"K Sunohara","year":"2024","unstructured":"Sunohara K, Onogi C, Tanaka A et al (2024) Association between alpha blocker use and the risk of fractures in patients with chronic kidney disease: a cohort study. BMC Nephrol 25:442. https:\/\/doi.org\/10.1186\/s12882-024-03892-5","journal-title":"BMC Nephrol"},{"key":"1607_CR39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2796.2003.01227.x","volume":"254","author":"PC Souverein","year":"2003","unstructured":"Souverein PC, Van Staa TP, Egberts ACG et al (2003) Use of \u03b1-blockers and the risk of hip\/femur fractures. J Intern Med 254:548\u2013554. https:\/\/doi.org\/10.1111\/j.1365-2796.2003.01227.x","journal-title":"J Intern Med"},{"key":"1607_CR40","doi-asserted-by":"publisher","first-page":"101501","DOI":"10.1016\/j.jocd.2024.101501","volume":"27","author":"D Dutta","year":"2024","unstructured":"Dutta D, Nagendra L, Chandran M et al (2024) Impact of pheochromocytoma or paraganglioma on bone metabolism: a systemic review and meta-analysis. J Clin densitometry 27:101501. https:\/\/doi.org\/10.1016\/j.jocd.2024.101501","journal-title":"J Clin densitometry"},{"key":"1607_CR41","doi-asserted-by":"publisher","first-page":"115221","DOI":"10.1016\/j.bone.2020.115221","volume":"133","author":"M Yokomoto-Umakoshi","year":"2020","unstructured":"Yokomoto-Umakoshi M, Umakoshi H, Fukumoto T et al (2020) Pheochromocytoma and paraganglioma: an emerging cause of secondary osteoporosis. Bone (New York NY) 133:115221. https:\/\/doi.org\/10.1016\/j.bone.2020.115221","journal-title":"Bone (New York NY)"},{"key":"1607_CR42","doi-asserted-by":"publisher","unstructured":"Yokomoto-Umakoshi M, Umakoshi H, Sakamoto R et al (2021) Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma. Bone 142. https:\/\/doi.org\/10.1016\/j.bone.2020.115607","DOI":"10.1016\/j.bone.2020.115607"},{"key":"1607_CR43","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1210\/jc.2017-00169","volume":"102","author":"B-J Kim","year":"2017","unstructured":"Kim B-J, Kwak MK, Ahn SH et al (2017) Lower bone mass and higher bone resorption in pheochromocytoma: importance of sympathetic activity on human bone. J Clin Endocrinol Metab 102:2711\u20132718. https:\/\/doi.org\/10.1210\/jc.2017-00169","journal-title":"J Clin Endocrinol Metab"},{"key":"1607_CR44","doi-asserted-by":"publisher","first-page":"E2093","DOI":"10.1210\/jc.2012-2823","volume":"97","author":"AG Veldhuis-Vlug","year":"2012","unstructured":"Veldhuis-Vlug AG, El Mahdiui M, Endert E et al (2012) Bone resorption is increased in pheochromocytoma patients and normalizes following adrenalectomy. J Clin Endocrinol Metab 97:E2093\u2013E2097. https:\/\/doi.org\/10.1210\/jc.2012-2823","journal-title":"J Clin Endocrinol Metab"},{"key":"1607_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2018.06.023","volume":"116","author":"B-J Kim","year":"2018","unstructured":"Kim B-J, Kwak MK, Kim JS et al (2018) Higher sympathetic activity as a risk factor for skeletal deterioration in pheochromocytoma. Bone (New York NY) 116:1\u20137. https:\/\/doi.org\/10.1016\/j.bone.2018.06.023","journal-title":"Bone (New York NY)"},{"key":"1607_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ijem.ijem_322_22","volume":"27","author":"S Khatiwada","year":"2023","unstructured":"Khatiwada S, Agarwal S, Kandasamy D et al (2023) Prevalence and predictors of osteoporosis\/bmd below expected range for age in pheochromocytoma\/paraganglioma and BMD, TBS change post-operatively: a prospective cohort study. Indian J Endocrinol Metab 27:87\u201390. https:\/\/doi.org\/10.4103\/ijem.ijem_322_22","journal-title":"Indian J Endocrinol Metab"},{"key":"1607_CR47","doi-asserted-by":"publisher","first-page":"115607","DOI":"10.1016\/j.bone.2020.115607","volume":"142","author":"M Yokomoto-Umakoshi","year":"2021","unstructured":"Yokomoto-Umakoshi M, Umakoshi H, Sakamoto R et al (2021) Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma. Bone (New York NY) 142:115607. https:\/\/doi.org\/10.1016\/j.bone.2020.115607","journal-title":"Bone (New York NY)"},{"key":"1607_CR48","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00198-020-05527-5","volume":"31","author":"M Yokomoto-Umakoshi","year":"2020","unstructured":"Yokomoto-Umakoshi M, Umakoshi H, Ogata M et al (2020) Coexistence of osteoporosis and atherosclerosis in pheochromocytoma: new insights into its long-term management. Osteoporos Int 31:2151\u20132160. https:\/\/doi.org\/10.1007\/s00198-020-05527-5","journal-title":"Osteoporos Int"},{"key":"1607_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12020-021-02806-x","volume":"74","author":"E Shevroja","year":"2021","unstructured":"Shevroja E, Cafarelli FP, Guglielmi G, Hans D (2021) DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine 74:20\u201328","journal-title":"Endocrine"},{"key":"1607_CR50","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40618-023-02198-x","volume":"47","author":"W Qi","year":"2024","unstructured":"Qi W, Cui L, Jiajue R et al (2024) Deteriorated bone microarchitecture caused by sympathetic overstimulation in pheochromocytoma and paraganglioma. J Endocrinol Invest 47:843\u2013856. https:\/\/doi.org\/10.1007\/s40618-023-02198-x","journal-title":"J Endocrinol Invest"},{"key":"1607_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000431323","volume":"84","author":"I Ben-Skowronek","year":"2015","unstructured":"Ben-Skowronek I, Kozaczuk S (2015) Von hippel-lindau syndrome. Horm Res Paediatr 84:145\u2013152","journal-title":"Horm Res Paediatr"},{"key":"1607_CR52","doi-asserted-by":"publisher","first-page":"102193","DOI":"10.1016\/j.tranon.2024.102193","volume":"51","author":"Y Wang","year":"2025","unstructured":"Wang Y, Song J, Zheng S, Wang S (2025) Advancements in understanding the molecular mechanisms and clinical implications of Von Hippel-Lindau syndrome: A comprehensive review. Transl Oncol 51:102193. https:\/\/doi.org\/10.1016\/j.tranon.2024.102193","journal-title":"Transl Oncol"},{"key":"1607_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11914-019-00500-6","volume":"17","author":"CE Yellowley","year":"2019","unstructured":"Yellowley CE, Genetos DC (2019) Hypoxia signaling in the skeleton: implications for bone health. Curr Osteoporos Rep 17:26\u201335. https:\/\/doi.org\/10.1007\/s11914-019-00500-6","journal-title":"Curr Osteoporos Rep"},{"key":"1607_CR54","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1359\/jbmr.080233","volume":"23","author":"JF Griffith","year":"2008","unstructured":"Griffith JF, Yeung DKW, Tsang PH et al (2008) Compromised bone marrow perfusion in osteoporosis. J Bone Miner Res 23:1068\u20131075. https:\/\/doi.org\/10.1359\/jbmr.080233","journal-title":"J Bone Miner Res"},{"key":"1607_CR55","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.bone.2009.06.016","volume":"45","author":"YXJ Wang","year":"2009","unstructured":"Wang YXJ, Griffith JF, Kwok AWL et al (2009) Reduced bone perfusion in proximal femur of subjects with decreased bone mineral density preferentially affects the femoral neck. Bone 45:711\u2013715. https:\/\/doi.org\/10.1016\/j.bone.2009.06.016","journal-title":"Bone"},{"key":"1607_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bone.2018.08.022","volume":"116","author":"GG Loots","year":"2018","unstructured":"Loots GG, Robling AG, Chang JC et al (2018) Vhl deficiency in osteocytes produces high bone mass and hematopoietic defects. Bone 116:307\u2013314. https:\/\/doi.org\/10.1016\/j.bone.2018.08.022","journal-title":"Bone"},{"key":"1607_CR57","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jbmr.2087","volume":"29","author":"T Weng","year":"2014","unstructured":"Weng T, Xie Y, Huang J et al (2014) Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice. J Bone Miner Res 29:820\u2013829. https:\/\/doi.org\/10.1002\/jbmr.2087","journal-title":"J Bone Miner Res"},{"key":"1607_CR58","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bone.2011.12.003","volume":"50","author":"Q Zhao","year":"2012","unstructured":"Zhao Q, Shen X, Zhang W et al (2012) Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss. Bone 50:763\u2013770. https:\/\/doi.org\/10.1016\/j.bone.2011.12.003","journal-title":"Bone"},{"key":"1607_CR59","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1172\/JCI31581","volume":"117","author":"Y Wang","year":"2007","unstructured":"Wang Y, Wan C, Deng L et al (2007) The hypoxia-inducible factor \u03b1 pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616\u20131626. https:\/\/doi.org\/10.1172\/JCI31581","journal-title":"J Clin Invest"},{"key":"1607_CR60","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1631\/jzus.B2400406","volume":"26","author":"Z Wu","year":"2025","unstructured":"Wu Z, Dai Q, Wang Y et al (2025) Emerging roles of the metabolite succinate in bone-related diseases. J Zhejiang University-SCIENCE B 26:1137\u20131155. https:\/\/doi.org\/10.1631\/jzus.B2400406","journal-title":"J Zhejiang University-SCIENCE B"},{"key":"1607_CR61","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.3390\/nu15234895","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Han X, Shi J et al (2023) Distinct Metabolites in Osteopenia and Osteoporosis: A Systematic Review and Meta-Analysis. Nutrients 15:4895. https:\/\/doi.org\/10.3390\/nu15234895","journal-title":"Nutrients"},{"key":"1607_CR62","doi-asserted-by":"publisher","first-page":"101792","DOI":"10.1016\/j.ando.2025.101792","volume":"86","author":"A Jannin","year":"2025","unstructured":"Jannin A, Vieillard M-H, Lion G et al (2025) Bone, a double victim in metastatic catecholamine secreting tumors. Ann Endocrinol (Paris) 86:101792. https:\/\/doi.org\/10.1016\/j.ando.2025.101792","journal-title":"Ann Endocrinol (Paris)"},{"key":"1607_CR63","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jocd.2015.02.004","volume":"18","author":"JH Krege","year":"2015","unstructured":"Krege JH, Kendler D, Krohn K et al (2015) Relationship between vertebral fracture burden, height loss, and pulmonary function in postmenopausal women with osteoporosis. J Clin Densitometry 18:506\u2013511. https:\/\/doi.org\/10.1016\/j.jocd.2015.02.004","journal-title":"J Clin Densitometry"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01607-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01607-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01607-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:36:15Z","timestamp":1789738575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01607-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01607-6","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"18 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a narrative review and does not involve human participants or animals; therefore, ethical approval was not required.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"146"}}